Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Asset Utilization Ratio (2016 - 2025)

Cytosorbents' Asset Utilization Ratio history spans 14 years, with the latest figure at 0.82 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.82 for Q4 2025, up 10.19% from a year ago — trailing twelve months through Dec 2025 was 0.82 (up 10.19% YoY), and the annual figure for FY2025 was 0.81, up 14.1%.
  • Asset Utilization Ratio for Q4 2025 was 0.82 at Cytosorbents, up from 0.79 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.82 in Q4 2025 to a low of 0.46 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.68 (2023), against an average of 0.63.
  • The sharpest move saw Asset Utilization Ratio plummeted 39.18% in 2021, then skyrocketed 37.11% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.47 in 2021, then grew by 18.2% to 0.55 in 2022, then surged by 30.81% to 0.72 in 2023, then rose by 3.44% to 0.75 in 2024, then grew by 10.19% to 0.82 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.82, 0.79, and 0.73 for Q4 2025, Q3 2025, and Q2 2025 respectively.